Blue Sail Medical: Inventory Below Current Price Supports Production Through End of June, Ensuring Q2 Excess Profit
April 30 report, Blue Sail Medical stated in response to inquiries from investors that the current raw material inventory below the current price can support production until the end of June, ensuring extra profits in the second quarter. The company's core strategic partners include Qixiang Tengda, a leading enterprise with a complete integrated industry chain from butadiene to finished nitrile latex (relevant cooperation matters have been disclosed on designated information disclosure media). Additionally, there are nitrile latex production capacities from industrial investors as emergency reserves, and affiliated party Langhui Petrochemical ensures the supply of raw materials for PVC gloves. The supply of the two core glove products is competitive in both quantity and price.
【Copyright and Disclaimer】The above information is collected and organized by PlastMatch. The copyright belongs to the original author. This article is reprinted for the purpose of providing more information, and it does not imply that PlastMatch endorses the views expressed in the article or guarantees its accuracy. If there are any errors in the source attribution or if your legitimate rights have been infringed, please contact us, and we will promptly correct or remove the content. If other media, websites, or individuals use the aforementioned content, they must clearly indicate the original source and origin of the work and assume legal responsibility on their own.
Most Popular
-
A Look at the Material Suppliers Behind SpaceX
-
Government's Triple Action, Enterprises' Three Arrows in Five Days, Semiconductor Reshuffle! What Signal Does Japan's Chemical Industry Release?
-
Name change without tax change: POM Anti-Dumping Duty Rate Inheritance Implemented
-
Fire breaks out at jiangsu meiside!
-
Ethylene: Production Capacity Accelerates Expansion, Global Industry Landscape Is Being Reshaped
